According to Bafna Pharmaceuticals latest financial reports the total liabilities of BAFNAPH is $6.69M, an increase of 99.17% to 2022. At the end of 2022 company had $3.36M total liabilities. This figure represents the company's financial obligations and debts, including loans, accounts payable, and other liabilities that Bafna Pharmaceuticals is responsible for during its operational activities.
Year | Total liabilities | Change |
---|---|---|
2023 | $6.69M | 99.17% |
2022 | $3.36M | -5.10% |
2021 | $3.54M | 47.62% |
2020 | $2.40M | -77.91% |
2019 | $10.85M | - |